Michael W. Nall's most recent trade in Biocept Inc was a trade of 100,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 2, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocept Inc | Michael W. Nall | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Biocept Inc | Michael W. Nall | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 80,000 | 80,000 | - | - | Performance-Based Employee Stock Option (right to buy) |